Nanocan Therapeutics Corporation

📍 Princeton, United States🗓 Founded 2020👥 7 employees💰 Last funded May 2023
Biotechnology Research🌐 nanocan.life
Website LinkedIn
Nanocan Therapeutics Corporation is a Princeton, New Jersey based early stage biotechnology company developing cutting-edge, nanotechnology based innovations for therapeutic medicines to treat certain cancers where current interventions are insufficient. The Company’s inventions deploy smart radiotherapy biomaterials (nanoparticle drones), as a drug-delivery platform. Nanocan’s nanoparticle drones can be employed to sustainably deliver different drug payloads – including immunotherapy drugs, chemotherapy drugs, and phytomedicines – precisely to disease sites or targets, with greater therapeutic efficacy. Through its partnerships with leading academic research institutions, Nanocan is rapidly developing therapies that may ultimately result in new standards of care to help improve the lives of cancer patients. Nanocan is committed to making its disruptive innovations available to cancer patients in the U.S. and globally, including Low and Middle-Income Countries (“LMICs”), starting with countries in Africa.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nanocan Therapeutics Corporation?
Nanocan Therapeutics Corporation has 1 investors on record on gritt.io, 1 mid-stage.
When did Nanocan Therapeutics Corporation last raise funding?
The most recent investment in Nanocan Therapeutics Corporation recorded on gritt.io was in May 2023.
When was Nanocan Therapeutics Corporation founded?
Nanocan Therapeutics Corporation was founded in 2020.
What industry is Nanocan Therapeutics Corporation in?
Nanocan Therapeutics Corporation operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nanocan Therapeutics Corporation based?
Nanocan Therapeutics Corporation is headquartered in Princeton, United States.